Company

Aptose Biosciences Inc. (APTOF)

Standardized SEC financial data for Aptose Biosciences Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000882361 · OTC · Biological Products, (No Diagnostic Substances).

Return on equity

93.8%

Free cash flow

-$22.0M

Current ratio

0.69×

EPS (diluted)

$-10.41

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	—	$0	—	$0	$0	$0
R&D expense	$29.3M	$46.0M	$24.5M	$33.3M	$15.1M	$11.3M
SG&A expense	$26.5M	$19.5M	$14.5M	$15.6M	$11.2M	$13.4M
Income tax	—	—

Standardized from Aptose Biosciences Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$117.4M	$39.1M	$47.0M	$9.3M	$6.7M	$4.1M
Total current assets	$125.1M	$81.7M	$49.5M	$11.9M	$9.5M	$6.4M
Property, plant & equipment	$261K	$323K	$211K	$152K

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$33.9M	-$43.3M	-$32.3M	-$44.6M	-$36.0M	-$22.0M
Capital expenditures	$79K	$212K	$24K	$29K	$5K	$0
Free cash flow	-$34.0M	-$43.5M	-$32.3M	-$44.6M

Get APTOF data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/APTOF/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/APTOF/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View APTOF filings on SEC EDGAR →